German
Becker C, Fleischer S, Hack A, Hinderer J, Horn A, Scheible S, Can H, Muche R, Gebhard F,
Kinzl L, Nikolaus T. [Disabilities and handicaps due to hip fractures in the elderly]. ZGerontol Geriatr 1999 Oct;32(5):312-7.
Bickel C, Pantel J, Eysenbach K, Schroder J. Syntactic comprehension deficits in Alzheimer's
disease. Brain Lang 2000 Feb 15;71(3):432-48.
Buch K, Riemenschneider M, Bartenstein P, Willoch F, Muller U, Schmolke M, Nolde T,
Steinmann C, Guder WG, Kurz A. [Tau protein. A potential biological indicator forearly detection of Alzheimer disease]. Nervenarzt 1998 May;69(5):379-85.
Burkart M, Heun R, Maier W, Benkert O. [Dementia screening in routine clinical practice. A
comparative analysis of MMSE, SIDAM and ADAS]. Nervenarzt 1998 Nov;69(11):983-90.
Ermini-Funfschilling D, Meier D. [Memory training: an important constituent of milieu therapy
in senile dementia]. Z Gerontol Geriatr 1995 May;28(3):190-194.
Erzigkeit H, Lehfeld H, Pena-Casanova J, Bieber F, Yekrangi-Hartmann C, Rupp M, Rappard F,
Arnold K, Hindmarch I. The bayer-activities of daily living scale (b-adl): results from avalidation study in three european countries. Dement Geriatr Cogn Disord 2001 Sep-Oct;12(5):348-58.
Fichter MM, Bruce ML, Schroppel H, Meller I, Merikangas K. Cognitive impairment and
depression in the oldest old in a German and in U.S. communities. Eur Arch PsychiatryClin Neurosci 1995;245(6):319-25.
Forstl H, Sattel H, Sarochan M, Besthom C, Czech C, Daniel S, Geiger-Kabisch C, Hentschel F,
Zerfass R, Beyreuther K. [Alzheimer dementia and normal aging. Clinical,neuroradiologic, neurophysiologic and molecular biology follow-up data]. Nervenarzt1996 Sep;67(9):730-8.
Gattaz WF, Levy R, Cairns NJ, Forstl H, Braus DF, Maras A. [Relevance of metabolism of
membrane phospholipids for Alzheimer dementia]. Fortschr Neurol Psychiatr 1996Jan;64(1):8-12.
Gurtler K, Szecsey A, Stohr H. [Psychometric diagnosis of dementia in clinical gerontopsychiatry
practice]. Z Gerontol Geriatr 1998 Aug;31(4):281-5.
Hebenstreit GF, Fellerer K, Twerdy B, Pfeiffer KP, Zadravec S, Ferdinand P. [L-tryptophan in
pre-delirium and delirium conditions]. Infusionstherapie 1989 Apr;16(2):92-96.
Helmchen H, Reischies FM. [Normal and pathological cognitive aging]. Nervenarzt 1998
Hochrein A, Jonitz L, Hock C, Bell V, Plaum E, Engel RR. [Quantification of dementia-related
disabilities in daily behavior with the DAFS(Direct Assessment of Functional Status):
reliability and validity of a German test version]. Z Gerontol Geriatr 1996 May-Jun;29(3):216-22.
Hull M, Fiebich BL, Dykierek P, Schmidtke K, Nitzsche E, Orszagh M, Deuschl G, Moser E,
Schumacher M, Lucking C, Berger M, Bauer J. Early-onset Alzheimer's disease due tomutations of the presenilin-1 gene on chromosome 14: a 7-year follow-up of a patientwith a mutation at codon 139. Eur Arch Psychiatry Clin Neurosci 1998;248(3):123-9.
Inglin D. [Assessment of dementia]. Ther Umsch 1999 Feb;56(2):94-97.
Kafonek S, Ettinger WH, Roca R, Kittner S, Taylor N, German PS. Instruments for screening for
depression and dementia in a long-term care facility. J Am Geriatr Soc 1989Jan;37(1):29-34.
Kircher T, Stetter F, Wormstall H. [Use of supportive autogenic training in multiple morbidity in
geriatric psychiatry patients]. Z Gerontol Geriatr 1997 Sep-Oct;30(5):348-53.
Leblhuber F, Walli J, Tilz GP, Wachter H, Fuchs D. [Systemic changes of the immune system in
patients with Alzheimer's dementia]. Dtsch Med Wochenschr 1998 Jun 19;123(25-26):787-91.
Linden M, Kurtz G, Baltes MM, Geiselmann B, Lang FR, Reischies FM, Helmchen H.
[Depression in the very elderly]. Nervenarzt 1998 Jan;69(1):27-37.
Nikolaus T. [Geriatric assessment. The status of current knowledge with reference to suitability
criteria (discrimination, prediction, evaluation, practical aspects)]. Z Gerontol Geriatr2001 May;34:36-42.
Noser A, Schonenberger PM, Wettstein A. [Comparative study between the Folstein mini-mental
state and the Zurich variant in demented and non-demented patients]. Schweiz ArchNeurol Psychiatr 1988;139(3):69-77.
Pantel J, Schroder J, Schmitt R, Schad LR, Knopp MV, Geissler M, Uhde WH, Bluml S,
Friedlinger M, Klemenz M, Essig M, Sauer H. [Quantitative magnetic resonancetomography and the severity of deficits in dementia of the Alzheimer type]. Nervenarzt1996 Jan;67(1):46-52.
Rabins PV, Black B, German P, Roca R, McGuire M, Brant L, Cook J. The prevalence of
psychiatric disorders in elderly residents of public housing. J Gerontol A Biol Sci MedSci 1996 Nov;51(6):M319-24.
Reisberg B, Finkel S, Overall J, Schmidt-Gollas N, Kanowski S, Lehfeld H, Hulla F, Sclan SG,
Wilms HU, Heininger K, Hindmarch I, Stemmler M, Poon L, Kluger A, Cooler C,Bergener M, Hugonot-Diener L, Robert PH, Antipolis S, Erzigkeit H. The Alzheimer'sdisease activities of daily living international scale (ADL-IS). Int Psychogeriatr 2001Jun;13(2):163-181.
Reisecker F, Koltringer P, Lind P, Leblhuber F, Eber O. [Lack of specificity of single photon
emission computerized tomography in dementia-results of a case of progressiveparalysis]. Nervenarzt 1992 Jun;63(6):371-374.
Sandholzer H, Breull A, Fischer GC. [Early diagnosis and early treatment of cognitive disorders:
a study of geriatric screening of an unselected patient population in general practice]. ZGerontol Geriatr 1999 Jun;32(3):172-8.
Satzger W, Hampel H, Padberg F, Burger K, Nolde T, Ingrassia G, Engel RR. [Practical
application of the CERAD test battery as a neuropsychological dementia screening test]. Nervenarzt 2001 Mar;72(3):196-203.
Schmeling-Kludas C, Jager K, Niemann BM. [Diagnosis and significance of psychiatric disorders
in physically ill geriatric patients]. Z Gerontol Geriatr 2000 Feb;33(1):36-43.
Schmidgen H, Hoell T, Regard M, Landis T, Rudolf KH, Berzewski H, Brock M. [The
Neuropsychological Screening Test (NST): initial validation and reliability studies]. Zentralbl Neurochir 1994;55(4):185-192.
Schone W, Ludwig M. [Paroxetine in the treatment of depression in geriatric patients--a double-
blind comparative study with fluoxetine]. Fortschr Neurol Psychiatr 1994 Sep;62 Suppl1:16-8.
Schumacher J, Zedlick D, Frenzel G. [Depressive mood and cognitive impairment in results of
old age nursing homes]. Z Gerontol Geriatr 1997 Jan;30(1):46-53.
Zachhuber C, Leblhuber F, Jellinger K, Bancher C, Drlicek M. [Histopathologic studies in
dementia-comparison with clinical findings]. Z Gerontol Geriatr 1997 Jan;30(1):29-33.
Walzl M, Walzl B, Kleinert G, Schied G, Lechner H. [Heparin-induced extracorporeal LDL
precipitation (HELP). A new therapeutic possibility in cerebral multi-infarct dementia]. Nervenarzt 1993 Oct;64(10):648-652.
CARNEGIE FUND III, SICAV UNAUDITED SEMI-ANNUAL REPORT JUNE 30, 2008 Subscriptions are only valid if made on the basis of the current prospectus accompanied by the latestannual and the latest semi-annual report if published after the annual report TABLE OF CONTENTS Statement of Operations and Changes in Net AssetsStatement of Changes in Number of Shares Outstanding Carnegie Fund III
Prostate Cancer Studies STUDIES CURRENTLY RECRUITING ARN-509 - SPARTAN Study Phase III study comparing ARN-509 (pill) to placebo for patients with non-metastatic prostate cancer Recruiting Galeterone - TOK ARMOR 2 study 2 part Phase II study of galeterone -TOK (pill) for patients with metastatic prostate cancer pre and post-chemotherapy Recruiting Genentec G